Incyte Corporation (INCY) Stock Analysis

Incyte Corporation (INCY) Stock Analysis — AI Research | MarketCI

INCY

Market Closed

Incyte Corporation

NASDAQHealthcare Biotechnology

2.62K employees

CEO: William J. Meury

Founded: 1993

$98.22

+$0.00(+NaN%)

Market Cap

19.62B

Beta

0.79

52W Range

N/A

Dividend Yield

0.00%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

INCY Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for INCY built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Buy

Pass %

71.43%

Score

5/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$122.04

AI Price Target

Machine learning • Price prediction

$88.80

Market Sentiment

News & social media analysis

0.10

Value Investor Price

Classic value analysis

$30.88

Financial Health

Bankruptcy risk assessment

8.89

Quality Score

Financial strength rating

6.00

AI Investment Grade

Deep analysis of filings & news

75.00

Key Investment Highlights

Important factors affecting INCY investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

82.05% Excellent

Conditions Met

32.00/39.00

Due Diligence Score

82.05%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions